Presentation at ISAM May 2021, Boise Idaho
SolAeroMed CEO presented clinical study results in Bronchiectasis at the International Socieity of Aerosol Medicine meeting in Boise Idaho in May 2021. Ensuing discussion led to 3rd party interest from US clinicians to engage in future clinical trials of S1226.